182 related articles for article (PubMed ID: 12951850)
1. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
Petersen TM; Larsen T; Nielsen HJ
Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
[TBL] [Abstract][Full Text] [Related]
2. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
3. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia.
Reuvekamp A; Velsing-Aarts FV; Poulina IE; Capello JJ; Duits AJ
Br J Obstet Gynaecol; 1999 Oct; 106(10):1019-22. PubMed ID: 10519425
[TBL] [Abstract][Full Text] [Related]
4. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application.
Lapaire O; Shennan A; Stepan H
Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):122-9. PubMed ID: 20457483
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
Stepan H; Unversucht A; Wessel N; Faber R
Hypertension; 2007 Apr; 49(4):818-24. PubMed ID: 17261644
[TBL] [Abstract][Full Text] [Related]
6. [Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction].
Semczuk-Sikora A; Krzyzanowski A; Stachowicz N; Robak J; Kraczkowski J; Kwiatek M; Semczuk M
Ginekol Pol; 2007 Oct; 78(10):783-6. PubMed ID: 18200969
[TBL] [Abstract][Full Text] [Related]
7. Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy.
Llurba E; Crispi F; Verlohren S
Fetal Diagn Ther; 2015; 37(2):81-92. PubMed ID: 25659427
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
Schlembach D; Wallner W; Sengenberger R; Stiegler E; Mörtl M; Beckmann MW; Lang U
Ultrasound Obstet Gynecol; 2007 Apr; 29(4):407-13. PubMed ID: 17330322
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia.
Polliotti BM; Fry AG; Saller DN; Mooney RA; Cox C; Miller RK
Obstet Gynecol; 2003 Jun; 101(6):1266-74. PubMed ID: 12798535
[TBL] [Abstract][Full Text] [Related]
11. An updated view on the origin and use of angiogenic biomarkers for preeclampsia.
Huppertz B
Expert Rev Mol Diagn; 2018 Dec; 18(12):1053-1061. PubMed ID: 30413130
[No Abstract] [Full Text] [Related]
12. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.
Taylor RN; Grimwood J; Taylor RS; McMaster MT; Fisher SJ; North RA
Am J Obstet Gynecol; 2003 Jan; 188(1):177-82. PubMed ID: 12548214
[TBL] [Abstract][Full Text] [Related]
13. [Growth factors in pregnancy complications with preeclampsia].
Bielecki DA; Klonowska-Dziatkiewicz E; Jarocki S; Urban J
Ginekol Pol; 2002 May; 73(5):422-9. PubMed ID: 12185701
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic factors for the prediction of preeclampsia in high-risk women.
Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of eNOS, VEGF, ACE and PlGF in maternal blood as predictors of impaired fetal growth in pregnancy complicated by gestational hypertension/preeclampsia.
Wender-Ozegowska E; Zawiejska A; Iciek R; Brązert J
Hypertens Pregnancy; 2015 Feb; 34(1):17-23. PubMed ID: 25181428
[TBL] [Abstract][Full Text] [Related]
17. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
[TBL] [Abstract][Full Text] [Related]
18. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels.
Madazli R; Aydin S; Uludag S; Vildan O; Tolun N
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):797-802. PubMed ID: 12911439
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
Unal ER; Robinson CJ; Johnson DD; Chang EY
Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
